Determination of the effective dose of bone marrow mononuclear cell therapy for bone healing in vivo.
Maren JankoSabrina PöllingerAlexander SchaibleMarlene BellenKatrin SchröderMyriam HeilaniCharlotte FremdlingIngo MarziChristoph NauDirk HenrichRené Danilo VerboketPublished in: European journal of trauma and emergency surgery : official publication of the European Trauma Society (2020)
It was shown that the effective dose of BMC for bone defect healing ranges from 2 × 106 BMC/mL to 1 × 107 BMC/mL. This concentration range seems to be the therapeutic window for BMC-supported therapy of large bone defects. However, further studies are necessary to clarify the exact BMC-dose dependent mechanisms of bone defect healing and to determine the therapeutically effective range more precisely.